New validation assays are set to enhance confidence in spatial transcriptomics as researchers deploy orthogonal techniques like multiplexed FISH and algorithmic benchmarks to address segmentation uncertainties. Current analytical frameworks support that identified spatial domains and gene modules largely reflect actual biological phenomena rather than AI-generated errors. As these systems converge on coherent biological signals, the implications for understanding diseases such as spinal muscular atrophy and ovarian pathology are profound, indicating a robust foundation for future diagnostic advancements.